Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Expert Review of Gastroenterology & Hepatology
|
September 4, 2020
Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, et al.
The Lancet. Digital Health
|
November 21, 2024
The new digital era in decompensated cirrhosis
Kohilan Gananandan, Konstantin Kazankov, Elliot B Tapper, et al.
Scandinavian Journal of Gastroenterology
|
August 1, 2024
Risk factors for acute myocardial infarction in patients with alcohol-related cirrhosis - a Danish nested case-control study
Emma Celia Herting, Rasmine Birn-Rydder, Konstantin Kazankov, et al.
Ugeskrift for Laeger
|
February 22, 2012
[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]
Sara Heebøll, Konstantin Kazankov, Marianne Kjær Poulsen, et al.
Expert Opinion on Therapeutic Targets
|
October 7, 2022
Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
Tea Lund Laursen, Anders Mellemkjær, Holger Jon Møller, et al.
World Journal of Gastroenterology
|
June 27, 2020
Liver-related effects of chronic hepatitis C antiviral treatment
Tea L Laursen, Thomas D Sandahl, Konstantin Kazankov, et al.
Physiological Reports
|
January 18, 2022
Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass
Konstantin Kazankov, Kirstine Nyvold Bojsen-Møller, Holger Jon Møller, et al.
Scandinavian Journal of Gastroenterology
|
October 15, 2019
QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites
Konstantin Kazankov, Henrik Kjaerulf Jensen, Hugh Watson, et al.
Journal of Hepatology
|
September 30, 2020
Macrophage markers and innate immunity in cirrhosis
Henning Grønbæk, Rasmus Hvidbjerg Gantzel, Tea Lund Laursen, et al.
Hepatology (Baltimore, Md.)
|
July 22, 2014
Reply: To PMID 24623375
Konstantin Kazankov, Holger Jon Møller, Bo Martin Bibby, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Expert Review of Gastroenterology & Hepatology
|
September 4, 2020
Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, et al.
The Lancet. Digital Health
|
November 21, 2024
The new digital era in decompensated cirrhosis
Kohilan Gananandan, Konstantin Kazankov, Elliot B Tapper, et al.
Scandinavian Journal of Gastroenterology
|
August 1, 2024
Risk factors for acute myocardial infarction in patients with alcohol-related cirrhosis - a Danish nested case-control study
Emma Celia Herting, Rasmine Birn-Rydder, Konstantin Kazankov, et al.
Ugeskrift for Laeger
|
February 22, 2012
[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]
Sara Heebøll, Konstantin Kazankov, Marianne Kjær Poulsen, et al.
Expert Opinion on Therapeutic Targets
|
October 7, 2022
Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
Tea Lund Laursen, Anders Mellemkjær, Holger Jon Møller, et al.
World Journal of Gastroenterology
|
June 27, 2020
Liver-related effects of chronic hepatitis C antiviral treatment
Tea L Laursen, Thomas D Sandahl, Konstantin Kazankov, et al.
Physiological Reports
|
January 18, 2022
Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass
Konstantin Kazankov, Kirstine Nyvold Bojsen-Møller, Holger Jon Møller, et al.
Scandinavian Journal of Gastroenterology
|
October 15, 2019
QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites
Konstantin Kazankov, Henrik Kjaerulf Jensen, Hugh Watson, et al.
Journal of Hepatology
|
September 30, 2020
Macrophage markers and innate immunity in cirrhosis
Henning Grønbæk, Rasmus Hvidbjerg Gantzel, Tea Lund Laursen, et al.
Hepatology (Baltimore, Md.)
|
July 22, 2014
Reply: To PMID 24623375
Konstantin Kazankov, Holger Jon Møller, Bo Martin Bibby, et al.
Page
of 4